Lymphoma Research Foundation News Room:

FDA Approves New Therapy
New therapy for patients with relapsed or refractory peripheral T-cell lymphoma

Radioimmunotherapy Drug Receives Expanded Label Approval
Zevalin received expanded label approval from the FDA

Latest Results on Genmab’s Arzerra Look Promising
Previously untreated follicular lymphoma patients may benefit

Novel Tumor Suppressor Discovered
Finding could lead to new therapies for blood cancers; including some types of lymphoma

New and Exciting Developments in Mantle Cell Lymphoma
Presented at the 2009 American Society of Oncology (ASCO) Annual Meeting

PRESS RELEASE _ 6/23/09 - Order Your Copy of the 6th Annual Mantle Cell Consortium Scientific Workshop
A Research Report from the 6th Annual Mantle Cell Lymphoma Scientific Workshop, detailing each oral and poster presentation as well as the roundtable discussions, is now available.

Seattle News Anchor Goes Public With Hodgkin Lymphoma Battle
Join Bill Wixey, Q 13 Fox, on his personal journey against Hodgkin lymphoma.

Lymphoma Vaccine Shows Promise
A pivotal phase III trial of BiovaxID shows promising results in follicular lymphoma.

4/29/09 - Updated Non-Hodgkin Lymphoma (NHL) Guidelines
The National Comprehensive Cancer Network Announces New Guidelines for Primary Cutaneous B-Cell Lymphoma and Updated Guidelines for NHL

4/13/09 - New RIT Method Effectively Targets and Treats T-cell non-Hodgkin lymphoma
Ajay Gopal, MD, LRF grant recipient, discovers that a novel method for delivering RIT in mantle cell lymphoma shows promise in T-cell non-Hodgkin lymphoma.